Skip to content

HUMAN MONONUCLEAR CELL INDUCED PLURIPOTENT CELL EXOSOMES

55

Safety score · 0–100

Moderate

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

Exosomes — tiny signaling vesicles — shed by induced pluripotent stem cells (iPSCs) originally derived from human mononuclear blood cells. These nanoparticle 'messengers' carry growth factors, RNA, and lipids that can theoretically rejuvenate skin, but their use raises significant safety and ethical questions.

Induced pluripotent stem cells (iPSCs) are created by reprogramming differentiated cells (here, mononuclear cells from blood — monocytes and lymphocytes) back to a pluripotent state using Yamanaka factors (OCT4, SOX2, KLF4, c-MYC). These iPSCs then secrete exosomes (40–150 nm vesicles) into their conditioned culture media. The exosomes contain: growth factors (VEGF, FGF, TGF-β), cytokines, transcription factor mRNA/miRNA, and lipid rafts. These cargoes can influence gene expression in recipient skin cells, theoretically promoting fibroblast proliferation and collagen production. However, the tumorigenicity risk of iPSC-derived products is the primary safety concern — undifferentiated iPSCs that might contaminate the product could form teratomas. Rigorous iPSC purity testing is essential.

Function

ANTIMICROBIAL, ANTIOXIDANT, SKIN CONDITIONING - MISCELLANEOUS

Skin benefits

  • Growth factors may stimulate collagen and elastin production
  • miRNA cargo could influence skin rejuvenation gene expression
  • Potential for improved skin barrier function
  • Antioxidant and anti-inflammatory effects from exosome contents
  • May reduce signs of skin aging

Known concerns

  • Tumorigenicity risk — undifferentiated iPSC contamination could theoretically form teratomas
  • EU cosmetics regulation scrutinizes stem cell-derived ingredients closely
  • Growth factors in exosomes may trigger abnormal cell proliferation
  • Ethical concerns around iPSC derivation from human cells
  • Requires extensive pathogen screening of donor cells
  • Long-term effects of altering skin gene expression are unknown

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Check your shelf

Find HUMAN MONONUCLEAR CELL INDUCED PLURIPOTENT CELL EXOSOMES in your products.

Scan any cosmetic product with LuxSense to see if it contains HUMAN MONONUCLEAR CELL INDUCED PLURIPOTENT CELL EXOSOMES and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.